GoodRx Holdings, Inc. (GDRX) Tops Q3 EPS by 1c

GoodRx Holdings, Inc. (NASDAQ: GDRX) reported Q3 EPS of $0.09, $0.01 better than the analyst estimate of $0.08. Revenue for the quarter came in at $140.45 million versus the consensus estimate of $135.06 million.

GUIDANCE:

GoodRx Holdings, Inc. sees Q4 2020 revenue of $148 million, versus the consensus of $144 million.

• Adjusted EBITDA Margin 30.0% – 31.0%

For earnings history and earnings-related data on GoodRx Holdings, Inc. (GDRX) click here.

You May Also Be Interested In

• Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
• AbbVie updates 2026 EPS guidance after $291M IPR&D charge
• Nvidia underperforms peers as report sparks rack delay worries